In chronic coronary syndrome, women less likely to get cholesterol-lowering drugs vs. men
Among patients with chronic coronary syndrome, women were less likely than men to be treated with lipid-lowering therapy, researchers reported at ESC Preventive Cardiology 2024.Women in this population were also less likely than men to be treated aggressively for lipid-lowering and to achieve LDL goals, the researchers found.